Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Freight Technologies, Inc. Announces Conversion of $3.55M Convertible Debt to Equity
-
Lavoro Completes Acquisition of Coram
-
Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108
-
Lavoro Announces a New R$420 Million 4-Year Secured Credit Facility
-
BIGG Digital Assets Announces Board of Directors Changes
-
Banzai Celebrates a Year of Unprecedented Growth and Innovation in 2023
-
Schouw & Co. share buy-back programme, week 51 2023
-
Society Pass Inc. (Nasdaq: SOPA): Litchfield Hills Initiates Equity Research Coverage; SOPA Growing Rapidly and Nearing Positive EBITDA Inflection
-
Medigus: Charging Robotics Announces Positive Results in Transferring High Voltage Wireless Electricity Needed for EV Charging
-
Form 8.3 - LXi REIT plc
-
Form 8.3 - Young & Co's Brewery plc
-
Form 8.3 - LondonMetric Property plc
-
Turbo Energy Appoints Mariano Soria as CEO of the Company with Enrique Selva to Remain as a Chairman of the Board
-
Charging Robotics Announces Positive Results in Transferring High Voltage Wireless Electricity Needed for EV Charging
-
Turbo Energy Appoints Mariano Soria as CEO of the Company with Enrique Selva to Remain as a Chairman of the Board
-
Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.
-
HUISON DHA appeared in International Forum on Omega-3 and Global Health
-
Standard Uranium Signs Definitive Agreement to Option Canary Project in Athabasca Basin
-
Where Food Comes From, Inc. Acquires Upcycled Certified® Program as Reducing Food Waste Through Upcycling Becomes Fastest Growing Consumer Trend
-
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
-
Par Pacific Management to Participate in Investor Conferences
-
HUISON DHA appeared in International Forum on Omega-3 and Global Health
-
Turbo Energy Announces Interim Results for the Period Ended June 30, 2023
-
WiMi Built an Efficient, Blockchain-compatible Heterogeneous Computing Framework
-
Vera Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
-
Form 8.3 - Dechra Pharmaceuticals PLC
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
Dickey’s Barbecue Pit Offering Kids Eat Free for January 2024
-
Data on debtor composition
-
Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
-
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
-
Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides
-
Surge Copper Acquires 100% Interest in Berg
-
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
-
Wearable Devices Ramps Up Inventory in Anticipation of its Participation at the 2024 CES Showcase
-
Major shareholder announcement
-
Monopoly Finance Announces Mono Coin Launch on January 24th
-
Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer
-
Algernon Pharmaceuticals Announces Increase to Private Placement
-
Broadwind Announces Agreement to Sell Approximately $15 Million of IRA Advanced Manufacturing Tax Credits
-
Synlogic Announces Contract with the Air Force Research Lab
-
Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend
-
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LXI REIT PLC
-
HONKARAKENNE OYJ - MANAGERS’ TRANSACTIONS – SAARELAINEN, MARKO
-
Plug Power Completes First Installation of Electrolyzer at Amazon Fulfillment Center
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LONDONMETRIC PROPERTY PLC
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LONDONMETRIC PROPERTY PLC
-
Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference


